Searchable abstracts of presentations at key conferences in endocrinology

ea0084ps3-12-107 | Graves’ Disease 2 and Orbitopathy | ETA2022

Macrophage-orbital fibroblasts interaction in context of hypoxic signaling for inflammatory processes during graves’ orbitopathy

Gortz Gina-Eva , Eckstein Anja , Jesenek Christoph , Horstmann Mareike , Philipp Svenja , Bruderek Kirsten , Oeverhaus Michael , Daser Anke , Bechrakis Nikolaos , Brandau Sven , Berchner-Pfannschmidt Utta

Introduction: The inflammatory eye disease Graves’ orbitopathy (GO) is the main complication of Graves’ disease in patients. In previous studies we have shown that hypoxia and HIF-1 dependent pathways could play an important role in the pathogenic process of GO. Hypoxia is known to attract inflammatory cells and therefore maintains inflammation and recruitment of immune cells like macrophages (MQ). However, few is known about the specific contribution of MQ to the pr...

ea0092op-09-03 | Oral Session 9: Thyroid Eye Disease | ETA2023

Linsitinib, AN IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease

Gulbins Anne , Horstmann Mareike , Daser Anke , Flogel Ulrich , Oeverhaus Michael , Bechrakis Nikolaos , Paul Banga J , Keitsch Simone , Wilker Barbara , Krause Gerd , Hammer Gary , Spencer Andy , Zeidan Ryan , Eckstein Anja , Philipp Svenja , Gortz Gina-Eva

Study objective: We investigated the effect of linsitinib, a dual small-molecule kinase inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) and the Insulin receptor (IR), on Graves’ Disease and thyroid eye disease. Graves‘ disease (GD), also known as ‘Basedow’s disease‘, is the most common cause for hyperthyroidism, typically presenting in patients between 40-60 years. GD is an autoimmune condition of the thyroid which is caused by autoanti...